Xiaoyu Jiang

538 total citations
17 papers, 368 citations indexed

About

Xiaoyu Jiang is a scholar working on Hematology, Genetics and Immunology. According to data from OpenAlex, Xiaoyu Jiang has authored 17 papers receiving a total of 368 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Hematology, 7 papers in Genetics and 5 papers in Immunology. Recurrent topics in Xiaoyu Jiang's work include Blood groups and transfusion (8 papers), Chronic Lymphocytic Leukemia Research (4 papers) and Platelet Disorders and Treatments (4 papers). Xiaoyu Jiang is often cited by papers focused on Blood groups and transfusion (8 papers), Chronic Lymphocytic Leukemia Research (4 papers) and Platelet Disorders and Treatments (4 papers). Xiaoyu Jiang collaborates with scholars based in United States, Germany and Italy. Xiaoyu Jiang's co-authors include Alexander Röth, Catherine M. Broome, Wilma Barcellini, Shirley D’Sa, Marc Michel, Bernd Jilma, Sigbjørn Berentsen, David J. Kuter, Tor Henrik Anderson Tvedt and Yoshitaka Miyakawa and has published in prestigious journals such as New England Journal of Medicine, Blood and Neurology.

In The Last Decade

Xiaoyu Jiang

16 papers receiving 359 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xiaoyu Jiang United States 9 215 131 130 49 41 17 368
Yotaro Tamai Japan 9 44 0.2× 53 0.4× 38 0.3× 27 0.6× 6 0.1× 57 258
Irfan Khan India 9 44 0.2× 19 0.1× 54 0.4× 17 0.3× 19 0.5× 49 270
Sheila Bandyopadhyay United States 9 54 0.3× 62 0.5× 86 0.7× 41 0.8× 34 0.8× 14 347
Shinji Mochizuki Japan 11 71 0.3× 48 0.4× 103 0.8× 17 0.3× 38 0.9× 28 387
O. Drummond United Kingdom 13 166 0.8× 22 0.2× 41 0.3× 20 0.4× 16 0.4× 25 558
Neusa Pereira da Silva Brazil 10 39 0.2× 140 1.1× 21 0.2× 17 0.3× 24 0.6× 20 338
Huimin Jin China 11 24 0.1× 43 0.3× 35 0.3× 14 0.3× 36 0.9× 29 323
Ángela M. Álvarez Colombia 10 41 0.2× 106 0.8× 18 0.1× 5 0.1× 38 0.9× 30 327
Rachel L. Smith United States 5 115 0.5× 111 0.8× 45 0.3× 16 0.3× 11 0.3× 7 222
Diana Bareyan United States 9 21 0.1× 183 1.4× 36 0.3× 8 0.2× 25 0.6× 9 347

Countries citing papers authored by Xiaoyu Jiang

Since Specialization
Citations

This map shows the geographic impact of Xiaoyu Jiang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaoyu Jiang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaoyu Jiang more than expected).

Fields of papers citing papers by Xiaoyu Jiang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaoyu Jiang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaoyu Jiang. The network helps show where Xiaoyu Jiang may publish in the future.

Co-authorship network of co-authors of Xiaoyu Jiang

This figure shows the co-authorship network connecting the top 25 collaborators of Xiaoyu Jiang. A scholar is included among the top collaborators of Xiaoyu Jiang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaoyu Jiang. Xiaoyu Jiang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
2.
Röth, Alexander, Wilma Barcellini, Tor Henrik Anderson Tvedt, et al.. (2022). Sutimlimab improves quality of life in patients with cold agglutinin disease: results of patient-reported outcomes from the CARDINAL study. Annals of Hematology. 101(10). 2169–2177. 13 indexed citations
3.
Röth, Alexander, Wilma Barcellini, Shirley D’Sa, et al.. (2022). Complement C1s inhibition with sutimlimab results in durable response in cold agglutinin disease: CARDINAL study 1-year interim follow-up results. Haematologica. 107(7). 1698–1702. 21 indexed citations
4.
Röth, Alexander, Sigbjørn Berentsen, Wilma Barcellini, et al.. (2022). Sutimlimab in patients with cold agglutinin disease: results of the randomized placebo-controlled phase 3 CADENZA trial. Blood. 140(9). 980–991. 66 indexed citations
5.
Röth, Alexander, Catherine M. Broome, Wilma Barcellini, et al.. (2022). Sutimlimab provides clinically meaningful improvements in patient‐reported outcomes in patients with cold agglutinin disease: Results from the randomised, placebo‐controlled, Phase 3 CADENZA study. European Journal Of Haematology. 110(3). 280–288. 10 indexed citations
6.
Ma, Di, et al.. (2021). Posterior Reversible Encephalopathy Syndrome Associated With Anlotinib: A Case Report and Literature Review. Frontiers in Neurology. 12. 546481–546481. 4 indexed citations
7.
Berentsen, Sigbjørn, Wilma Barcellini, Shirley D’Sa, et al.. (2021). Inhibition of Complement C1s By Sutimlimab in Patients with Cold Agglutinin Disease (CAD): Efficacy and Safety Results from the Randomized, Placebo-Controlled Phase 3 CADENZA Study. Blood. 138(Supplement 1). 349–349. 6 indexed citations
8.
Chen, Yubin, et al.. (2021). Endoscopic Transcanal Push-Trough Myringoplasty for Different Types of Tympanic Membrane Perforations. Otology & Neurotology. 42(5). 726–732. 5 indexed citations
9.
Röth, Alexander, Wilma Barcellini, Shirley D’Sa, et al.. (2021). Sutimlimab in Cold Agglutinin Disease. New England Journal of Medicine. 384(14). 1323–1334. 127 indexed citations
10.
Broome, Catherine M., Alexander Röth, David J. Kuter, et al.. (2020). Long-Term Safety and Efficacy of Sutimlimab in Patients with Chronic Immune Thrombocytopenia. Blood. 136(Supplement 1). 14–15. 12 indexed citations
11.
Jiang, Xiaoyu, Ying Zhang, Xiang Yin, et al.. (2020). A novel CCM3 mutation associated with cerebral cavernous malformation in a Chinese family. Therapeutic Advances in Neurological Disorders. 13. 1279124232–1279124232. 1 indexed citations
12.
Röth, Alexander, Wilma Barcellini, Shirley D’Sa, et al.. (2020). Inhibition of Complement C1s with Sutimlimab in Patients with Cold Agglutinin Disease (CAD): Interim Results of the Phase 3 Cardinal Study Long-Term Follow-up. Blood. 136(Supplement 1). 24–25. 2 indexed citations
13.
Kappos, Ludwig, Helmut Butzkueven, Tim Spelman, et al.. (2019). Real-world data from over 10 years in the TYSABRI® Observational Program: Long-term safety and effectiveness of natalizumab in relapsing-remitting multiple sclerosis patients. Revue Neurologique. 175. S101–S102. 5 indexed citations
14.
Röth, Alexander, Wilma Barcellini, Shirley D’Sa, et al.. (2019). Inhibition of Complement C1s with Sutimlimab in Patients with Cold Agglutinin Disease (CAD): Results from the Phase 3 Cardinal Study. Blood. 134(Supplement_2). LBA–2. 8 indexed citations
15.
Liu, Mingjiang, Huanrong Li, Xiaoyu Jiang, et al.. (2014). The protective effect of caffeic acid against inflammation injury of primary bovine mammary epithelial cells induced by lipopolysaccharide. Journal of Dairy Science. 97(5). 2856–2865. 74 indexed citations
16.
Zheng, Yu, Shanshan Qu, Na Wang, et al.. (2012). Post-Stimulation Effect of Electroacupuncture at Yintang (EX-HN3) and GV20 on cerebral functional regions in healthy volunteers: A resting functional MRI study. Acupuncture in Medicine. 30(4). 307–315. 13 indexed citations
17.
Guo, Lin, et al.. (1968). [A microarray study on the molecular mechanism for the therapeutic effect of Antidotal and Myogenic Ointment on the foot ulcer in diabetic rats].. Medical Entomology and Zoology. 23(10). 621–4. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yotaro Tamai Breakdown of academic impact, for papers by Irfan Khan Breakdown of academic impact, for papers by Sheila Bandyopadhyay Breakdown of academic impact, for papers by Shinji Mochizuki Breakdown of academic impact, for papers by O. Drummond Breakdown of academic impact, for papers by Neusa Pereira da Silva Breakdown of academic impact, for papers by Huimin Jin Breakdown of academic impact, for papers by Ángela M. Álvarez Breakdown of academic impact, for papers by Rachel L. Smith Breakdown of academic impact, for papers by Diana Bareyan
Rankless by CCL
2026